Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	699.9	687.8	673.3	684.1	587	714.8
Revenue Growth (YoY)	2.70%	2.15%	-1.58%	16.54%	-17.88%	2.47%
Cost of Revenue	334	306.5	293.6	289.9	287.8	343.9
Gross Profit	365.9	381.3	379.7	394.2	299.2	370.9
Selling, General & Admin	318.7	321.1	321.4	326.5	257.2	327.2
Research & Development	9.1	12.4	12.6	29.2	30.6	34.9
Other Operating Expenses	3.7	3	3.3	3	7.3	4.4
Operating Expenses	331.5	336.5	337.3	358.7	295.1	366.5
Operating Income	34.4	44.8	42.4	35.5	4.1	4.4
Interest Expense	-8.7	-12.2	-15	-10	-3.3	-15.6
Interest & Investment Income	3.4	5.1	2.9	1.2	0.2	1.2
EBT Excluding Unusual Items	29.1	37.7	30.3	26.7	1	-10
Merger & Restructuring Charges	-8.5	-8.1	-28.2	-	-28.1	-25.4
Impairment of Goodwill	-413.5	-336.5	-	-	-	-
Asset Writedown	-100.2	-100.2	-	-	-	-
Legal Settlements	1.4	-	-10	-	-15	-27.5
Other Unusual Items	3.8	3.8	-	-	-	-
Pretax Income	-487.9	-403.3	-7.9	26.7	-42.1	-62.9
Income Tax Expense	-19.3	-17	2	5.2	-11.2	-33.9
Earnings From Continuing Operations	-468.6	-386.3	-9.9	21.5	-30.9	-29
Earnings From Discontinued Operations	-0.3	-5.8	-51.9	29	37.2	-
Net Income	-468.9	-392.1	-61.8	50.5	6.3	-29
Net Income to Common	-468.9	-392.1	-61.8	50.5	6.3	-29
Net Income Growth	-	-	-	701.59%	-	-
Shares Outstanding (Basic)	46	46	47	47	48	48
Shares Outstanding (Diluted)	46	46	47	47	49	48
Shares Change (YoY)	-0.48%	-1.29%	-1.48%	-2.67%	1.67%	0.42%
EPS (Basic)	-10.14	-8.52	-1.33	1.08	0.13	-0.61
EPS (Diluted)	-10.15	-8.53	-1.33	1.08	0.13	-0.61
EPS Growth	-	-	-	722.10%	-	-
Free Cash Flow	74.9	82.9	14.6	71.6	66.3	-22.7
Free Cash Flow Per Share	1.62	1.80	0.31	1.51	1.36	-0.47
Gross Margin	52.28%	55.44%	56.39%	57.62%	50.97%	51.89%
Operating Margin	4.92%	6.51%	6.30%	5.19%	0.70%	0.62%
Profit Margin	-67.00%	-57.01%	-9.18%	7.38%	1.07%	-4.06%
Free Cash Flow Margin	10.70%	12.05%	2.17%	10.47%	11.29%	-3.18%
EBITDA	74.5	90.3	85.9	76.7	42.4	47.3
EBITDA Margin	10.64%	13.13%	12.76%	11.21%	7.22%	6.62%
D&A For EBITDA	40.1	45.5	43.5	41.2	38.3	42.9
EBIT	34.4	44.8	42.4	35.5	4.1	4.4
EBIT Margin	4.92%	6.51%	6.30%	5.19%	0.70%	0.62%
Effective Tax Rate	-	-	-	19.48%	-	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q